SeekingAlpha.com: Virios Therapeutics seeks IPO for fibromyalgia pain treatment
It appears Innovative Med Concepts, the company that’s developing a potentially new fibromyalgia drug by combining existing antiviral and anti-inflammatory medications, has finally chosen a new financial partner. Virios is now preparing to raise funding for a future clinical trial.
From the article: “Now researchers at West Virginia University are working toward a vaccine that prevents humans from contracting the tick-borne illness that afflicts more than 300,000 Americans a year. Mariette Barbier, assistant professor in the School of Medicine’s Department of Microbiology, Immunology and Cell Biology, is leading the five-year project, which received $1.9 million from the National Institute of Allergy and Infectious Diseases.”
From the article: “Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, today announced that the first participant was enrolled in the Phase 3 RALLY study (TNX-CY-F306) of TNX-102 SL 5.6 mg for the management of fibromyalgia. RALLY is the Company’s second of two potentially pivotal Phase 3 studies of TNX-102 SL, a proprietary sublingual tablet formulation of cyclobenzaprine HCl taken daily at bedtime for the management of fibromyalgia.”
Pain News Network: DEA proposes cuts in opioid supply for fifth consecutive year
From the article: “For the fifth year in a row, the U.S. Drug Enforcement Administration is proposing significant cuts in the supply of hydrocodone, oxycodone and several other opioid pain medications classified as schedule II controlled substances. The cuts are partly based on a prediction by the Food and Drug Administration that medical need for the drugs will decline by over a third in 2021.”
From the article: “University of Idaho researchers are leading a nearly $6 million National Science Foundation (NSF) cooperative agreement, using large and complex data sets to improve prediction and response measures for tick-borne diseases.”
And an extra…
BusinessDen.com: Maker of mask designed to treat chronic pain raises $5.8M
From the article: “The U.S. Food and Drug Administration recently approved the medical mask, known as Sana, as a ‘general wellness device,’ but Hanbury is conducting trials to determine if it can treat patients with neuropathic pain or fibromyalgia, a disorder characterized by widespread musculoskeletal pain.”
The Fibro Summit…
(This section contains affiliate links.)
During the Fibro Summit on Sept. 28 through Oct. 4., “top functional medicine experts in gut and nervous system health, nutrition and brain health (and more) will share their insights, knowledge and the latest science on fibromyalgia: what it is (and isn’t), diagnostics, treatments and triggers. Discover what causes fibro, who gets it and why, and, most importantly, what can be done to overcome it,” according to the summit website.
The summit will cover the following topics:
- Understanding the root causes of fibromyalgia symptoms
- Improving sleep and boosting immunity
- Reducing pain and addressing inflammation
- Exploring the importance of good gut health and nutrition
- Leveraging fasting techniques for optimum health
- Addressing trauma, stress and the hidden causes of disease
Or you can use one of the links below to register and receive a free eBook or eReport:
- Good Gut Health Remedies eBook
- HealthMeans Fibromyalgia eBook
- Fibromyalgia and Deep Restorative Sleep Special eReport
- Treating and Beating Adrenal Fatigue Special eReport
Each day’s interviews will be available to watch for 24 hours, or you can watch at your leisure by purchasing the summit.
Question about covering summits…
I’m sure you guys have noticed there are A LOT of these online health summits now! I had a reader who suggested that I should start attending some of the summits and writing/recording short summaries of the talks since she doesn’t have time to watch/listen to them all.
Are there others who might be interested in this? Please comment below or if you’re on my email list, hit reply and let me know!